Universal Health Services, Inc. Class B (UHS)

NYSE Markedet er stengt

Universal Health Services, Inc. er en stor amerikansk helseoperatør med en portefølje som omfatter akuttsykehus, døgnbaserte enheter innen atferdshelse og tilknyttede polikliniske tjenester. Selskapet tilbyr sykehusbasert medisinsk behandling, akuttjenester, kirurgiske tjenester og spesialistbehandling gjennom sin akuttdivisjon, mens virksomheten innen atferdshelse er fokusert på psykiatrisk behandling, avhengighetsbehandling og andre psykiske helsetjenester for barn, ungdom og voksne.

Selskapets fotavtrykk er hovedsakelig konsentrert i USA, med særlig viktige operasjoner i delstater som Nevada, Texas og California. Det har også eksponering mot Storbritannia gjennom virksomhet innen atferdshelse, noe som gir konsernet en begrenset internasjonal tilstedeværelse. Universal Health Services driver et stort nettverk av døgnbaserte sentre for atferdshelse og akuttsykehus, støttet av polikliniske enheter som utvider tilbudet utover tradisjonelle sykehusmiljøer.

Et særtrekk ved Universal Health Services er balansen mellom de to viktigste forretningsområdene. Akuttsykehusene står for den største andelen av inntektene fordi de håndterer brede medisinske tjenester med høyt volum. Enheter innen atferdshelse har imidlertid en tendens til å være mer lønnsomme og står for en betydelig del av resultatet før skatt. Dette gir selskapet eksponering mot to viktige drivere for etterspørselen etter helsetjenester: generell sykehusbruk og det langsiktige behovet for behandling av psykisk helse og ruslidelser.

Som et børsnotert helseselskap påvirkes UHS av pasientvolumer, refusjonssatser, arbeidskostnader, regulering og de bredere økonomiske forholdene innen sykehusbehandling. Selskapets skala, geografiske konsentrasjon og ekspertise innen atferdshelse er sentrale for markedsposisjonen.

145.98 USD
143.24 USD
+3.43 (+2.41%)
Etter stengetid

Sist oppdatert

Markedsverdi
8.63B
P/E-tall
5.67
P/FCF-tall
9.72
P/S-tall
0.49
Selskapsverdi
13.22B
Sektor
Health Care
Bransje
General Medical and Surgical Hospitals
Adresse
367 S GULPH RD, KING OF PRUSSIA, PA, 19406
GlobeNewswire Inc.

U.S. Behavioral Health Market Size Expected to Reach USD 159.35 Bn by 2035

24. apr. 2026, 16:00 P.M.
GlobeNewswire Inc.

U.S. Mental Health Treatment Market Report and Directory 2026, Profiles of Acadia, Universal Health Services, Lyra Health, Spring Health, Headspace, Calm, Talkspace, BetterHelp, Carelon

12. jan. 2026, 13:59 P.M.
GlobeNewswire Inc.

Behavioral Rehabilitation Market to Witness 6.9% CAGR by 2031 | SkyQuest Technology

22. nov. 2024, 10:39 A.M.
GlobeNewswire Inc.

Behavioral Rehabilitation Market to Reach $777.2 Billion, Globally, by 2033 at 6.3% CAGR: Allied Market Research

30. sep. 2024, 13:01 P.M.
Zacks Investment Research

Baxter (BAX) Q2 Earnings Beat Estimates, '24 EPS View Raised

06. aug. 2024, 19:51 P.M.
Zacks Investment Research

Merit Medical (MMSI) Q2 Earnings & Revenues Beat, '24 View Up

02. aug. 2024, 16:55 P.M.
Zacks Investment Research

Zacks.com featured highlights Universal Health Services, Tenet Healthcare Corp., Century Communities and Magnite

02. aug. 2024, 14:43 P.M.
Zacks Investment Research

Zacks.com featured highlights Hilton Grand Vacations, Tenet Healthcare, Universal Health, Popular and B2Gold

31. juli 2024, 10:18 A.M.
Zacks Investment Research

HCA Healthcare (HCA) Beats on Q2 Earnings, Ups 2024 EPS View - Zacks Investment Research

23. juli 2024, 19:01 P.M.
Zacks Investment Research

Elanco (ELAN) Stock Declines After Sale of Aqua Business - Zacks Investment Research

22. juli 2024, 15:31 P.M.
Zacks Investment Research

4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates - Zacks Investment Research

19. juli 2024, 17:19 P.M.
Zacks Investment Research

BD (BDX) Up on Efforts to Tackle Blood Culture Vial Shortage - Zacks Investment Research

16. juli 2024, 17:31 P.M.
Zacks Investment Research

Terumo (TRUMY) Unit's SOFAST Study Shows Positive Results - Zacks Investment Research

15. juli 2024, 17:01 P.M.
Zacks Investment Research

Reasons to Retain Veeva Systems (VEEV) in Your Portfolio Now - Zacks Investment Research

15. juli 2024, 15:30 P.M.
Zacks Investment Research

3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now - Zacks Investment Research

15. juli 2024, 15:30 P.M.
Zacks Investment Research

Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now - Zacks Investment Research

12. juli 2024, 17:30 P.M.
Zacks Investment Research

Here's Why You Should Add DaVita (DVA) to Your Portfolio - Zacks Investment Research

12. juli 2024, 12:30 P.M.
Zacks Investment Research

IceCure's (ICCM) ProSense Breast Cancer Study Meets Endpoint - Zacks Investment Research

11. juli 2024, 18:30 P.M.
Zacks Investment Research

Reasons to Add Intuitive Surgical (ISRG) to Your Portfolio Now - Zacks Investment Research

11. juli 2024, 15:32 P.M.
Zacks Investment Research

Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028 - Zacks Investment Research

10. juli 2024, 16:30 P.M.
Markedsverdi
8.63B
Selskapsverdi
13.22B
P/E-tall
5.67
P/B-tall
1.16
P/S-tall
0.49
EV / EBITDA-forhold
4.95
EV / omsetning
0.74
Resultat per aksje
25.12
Utbytterente
0.75%
P/FCF-tall
9.72
P/CF-tall
4.53
Fri kontantstrøm
888M
Avkastning på egenkapital
20.37%
Avkastning på eiendeler
9.7%
Gjeld / egenkapital
0.63
Likviditetsgrad I
1.08
Likviditetsgrad II
1.01
Kontanter
0.04
Snittvolum
1.14M
Fundamentalpris (snapshot)
142.55

Resultatregnskap

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Omsetning 4.5B 4.49B 4.5B 4.28B 4.1B
Bruttofortjeneste 3.21B 4.49B 4.5B 4.28B 2.99B
Driftsresultat 502.86M 517.23M 521.69M 500.27M 454.83M
Driftsresultat før avskrivninger (EBITDA) 658.29M 680.57M 676.75M 652.27M 603.17M
Nettoresultat 348.68M 445.94M 372.96M 353.22M 316.68M
Grunnleggende EPS 5.71 7.15 5.92 5.49 4.87
Utvanet EPS 5.65 7.03 5.86 5.43 4.8

Balanse

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Sum eiendeler 15.68B 15.53B 15.34B 14.99B 14.88B
Sum gjeld 8.08B 8.12B 8.05B 7.84B 7.99B
Egenkapital 7.53B 7.34B 7.23B 7.09B 6.87B
Kontanter og ekvivalenter 119.03M 137.8M 112.9M 137.6M 126.75M
Omløpsmidler 3.5B 3.41B 3.26B 2.99B 3.08B
Kortsiktig gjeld 3.24B 3.24B 3.16B 2.32B 2.33B

Kontantstrøm

Post 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Kontantstrøm fra drift 401.63M 574.69M 380.68M 548.98M 360.05M
Kontantstrøm fra investeringer -197.58M -223.97M -269.41M -305.94M -271.3M
Kontantstrøm fra finansiering -221.89M -296.14M -134.52M -227.65M -91.42M
Endring i kontanter -18.77M 54.72M -24.8M 17.67M -1.03M
Type Rapport Dato Lenke
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 8-K — UNIVERSAL HEALTH SERVICES INC Vis rapport
eight k text 8-K — 8-K Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 8-K — UNIVERSAL HEALTH SERVICES INC Vis rapport
eight k text 8-K — 8-K Vis rapport
form 4 Form 4 — Nimetz Warren J. Vis rapport
form 4 Form 4 — Singer Maria Ruderman Vis rapport
form 4 Form 4 — McDonnell Eileen C. Vis rapport
form 4 Form 4 — SUSSMAN ELLIOT J MD MBA Vis rapport
form 4 Form 4 — Chen-Langenmayr Nina Vis rapport
edgar index 10-Q — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 8-K — UNIVERSAL HEALTH SERVICES INC Vis rapport
eight k text 8-K — 8-K Vis rapport
edgar index 8-K — UNIVERSAL HEALTH SERVICES INC Vis rapport
eight k text 8-K — 8-K Vis rapport
edgar index DEF 14A — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index ARS — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index DEFA14A — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 8-K — UNIVERSAL HEALTH SERVICES INC Vis rapport
eight k text 8-K — 8-K Vis rapport
edgar index SCHEDULE 13G/A — UNIVERSAL HEALTH SERVICES INC Vis rapport
form 4 Form 4 — FILTON STEVE Vis rapport
form 4 Form 4 — FILTON STEVE Vis rapport
form 4 Form 4 — FILTON STEVE Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — Peterson Matthew Jay Vis rapport
form 4 Form 4 — Sim Edward H Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
edgar index 4 — UNIVERSAL HEALTH SERVICES INC Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — Miller Marc D Vis rapport
form 4 Form 4 — FILTON STEVE Vis rapport
form 4 Form 4 — Peterson Matthew Jay Vis rapport
form 4 Form 4 — Sim Edward H Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport
form 4 Form 4 — MILLER ALAN B Vis rapport